 | Foretelling Lung Cancer Risk with AI Sybil—a new AI tool developed by KI member Regina Barzilay and Massachusetts General Hospital clinical collaborators Lecia Sequist and Florian Fintelmann—assesses a patient’s risk of lung cancer over six years by analyzing a single low-dose CT scan. Unlike current methods, Sybil can make accurate predictions without using demographic or medical information or a radiologist’s annotation. The tool, described in the Journal of Clinical Oncology, could be used to identify individuals who need additional testing and closer management and could be particularly useful given the rising incidence of lung cancer among non-smokers. MGH is launching a trial of Sybil, and researchers plan additional testing to ensure that it will maintain its accuracy across diverse populations. Barzilay and Sequist will share project updates as part of SOLUTIONS with/in/sight: Algorithm & Views on May 4. The work is funded in part by the Bridge Project. |
|
Farm Fresh Immunotherapy KI affiliate Tobi Oni is one of two Valhalla Fellows at the Whitehead Institute studying cancer and the immune system. Oni’s research focuses on how cell surface proteins and alpaca antibodies known as nanobodies can be used to disarm—and even fight back against—pancreatic cancer cells. |
|
|
Beyond Prostate Cancer The Yaffe Lab has discovered a mitotic mechanism that causes the combination of abiraterone, a standard treatment for prostate cancer, and Plk1-1 inhibitors to be more effective against prostate cancer than either drug alone. In a study appearing in Cancer Research and supported in part by the Bridge Project, they also found that the combination of abiraterone and the specific Plk1 inhibitor onvansertib was effective against a variety of other cancers beyond prostate cancer, including some types of pancreatic and ovarian cancers and acute myeloid leukemia. |
|
|
Kronos in Collaboration Kronos Bio, co-founded by Angela Koehler to tackle “undruggable” cancer targets, has launched a collaboration with Genentech. Genentech will leverage Kronos Bio’s drug discovery platform—including its small molecule microarray—to identify compounds that modify difficult-to-target transcription factors, with the aim of developing more effective treatments for cancer patients. |
|
|
Bonjour, Live μ Live μ, the first instrument of its kind in the U.S., has landed in the Peterson (1957) Nanotechnology Materials Facility at the Koch Institute. The French-manufactured high-pressured freezer allows scientists to execute a cutting-edge strategy called correlative light electron microscopy (CLEM), where fluorescent light microscopy and electron microscopy images are taken of the same sample. The Live μ, along with the Peterson Facility’s growing suite of resources and workflows, is available to the MIT community. The Live μ is one of a group of instruments acquired by the Peterson Facility through a gift from the Chau Hoi Shuen Foundation. |
|
|
Brush Up Your Combination Therapy A study appearing in Nature Nanotechnology describes how bottlebrush nanoparticles are able to co-deliver multiple cancer drugs to tumors. Working with former Charles W. (1955) and Jennifer C. Johnson Clinical Investigator Peter Ghoroghchian and others, KI member Jeremiah Johnson demonstrates how his lab’s signature technology allows researchers to adjust the ratio of drugs to maximize synergistic effects. The platform could be used to identify new combination therapies or improve effectiveness of already-approved drugs. |
|
|
Celebrating Together (Again) In late 2022 an in-person celebration of the recipients of the Peter Karches Mentorship Prize took place for the first time in three years, bringing together multiple cohorts of winners with family members and friends of Peter Karches to recognize their contributions. The 2022 awardees were Stephanie Gaglione, Sofia Hu, Allen Jiang, and Chris Nabel. |
|
|
It Takes All Kinases Michael Yaffe, together with longtime collaborators Lew Cantley and Benjamin Turk, created an atlas of protein kinases—signaling molecules that regulate nearly all cellular functions. This resource, described in Nature, could accelerate the pursuit of new cancer drugs and help physicians customize treatment to specific tumors. |
|
|
Science Surfaces Opens in the KI Public Galleries Science Surfaces, a capsule collection of student-designed body coverings and accessories inspired by the 2022 Image Awards exhibition, will be on display in the Koch Institute Public Galleries through April. The exhibition showcases the result of the inaugural Peers + Pros Project, a Boston Fashion Week creative learning initiative catalyzed by the Cambridge Science Festival and sponsored in part by Koch Institute. |
|
|
Thanks for the Cellular Memories Boyden Lab researchers programmed cells to produce protein chains that record the timing of gene and pathway activation during cellular events. The chains, described in in Nature Biotechnology, can be imaged through light microscopy. The technique could illuminate various cellular functions, including cancer-relevant processes like therapeutic response and gene expression. |
|
|
Committed to Caring MIT’s Office of Graduate Education posthumously recognizes KI member Angelika Amon as “Committed to Caring,” citing her generous and dynamic mentorship and her enduring support of students in and beyond the classroom. Amon’s legacy is further exemplified by the Amon Young Scientist Award. She is one of 15 faculty members in the current cohort of honorees, which includes KI member Michael Birnbaum, who was profiled in December. |
|
|
Suono Doses First Patient Langer/Traverso Lab startup Suono Bio has dosed its first patient with SuonoCalm, an ultrasound-based platform that enhances the delivery of nucleic acids, biologics, and other drugs that are too large or delicate to be absorbed effectively by the gastrointestinal tract. Clinical testing begins with a drug for ulcerative colitis (a known cancer risk factor) and could expand to additional diseases, including cancer. |
|
|
Unveiling the 2023 Image Awards Join us on Thursday, March 16 at 6:30 p.m. for the opening of the 13th annual Image Awards exhibition featuring extraordinary biomedical images from life sciences research at MIT. Lightning talks by the image creators will be followed by a dessert reception in the Koch Institute Public Galleries. Presentations will be delivered in person and livestreamed on Zoom. |
|
|
|
| | | | |
|
